HRS-6213

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-6213, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors [Phase 1, Phase 2]